Literature DB >> 8737007

The treatment of alcoholic hepatitis.

M Y Morgan1.   

Abstract

Alcoholic hepatitis is a precirrhotic lesion; it develops in only a minority of chronic alcohol abusers even after decades of abuse. The clinical spectrum of disease varies from asymptomatic hepatomegaly to florid hepatocellular failure with gastrointestinal bleeding and hepatic encephalopathy. Corresponding variation is observed both in morbidity and mortality. The majority of individuals with mild to moderate alcoholic hepatitis improve significantly following abstinence from alcohol and the provision of a diet sufficient to meet their nutritional requirements; their long-term outcome is determined largely by their ability to maintain abstinence from alcohol. Individuals with severe alcoholic hepatitis require intensive nutritional support and vigorous management of the complications of their liver injury; their outcome is generally poor. A small, carefully selected subgroup of these very sick patients may benefit, at least in the short-term, from treatment with corticosteroids; the place of orthotopic hepatic transplantation, in this patient group, is still the subject of debate. No other treatment modalities have been shown to confer benefit consistently. A number of new therapeutic approaches have been proposed and need to be explored.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8737007     DOI: 10.1093/oxfordjournals.alcalc.a008123

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  8 in total

1.  Alcoholic Liver Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-02

Review 2.  Alcoholic liver disease: treatment.

Authors:  Ki Tae Suk; Moon Young Kim; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 3.  Current Medical Treatment for Alcohol-Associated Liver Disease.

Authors:  Gustavo Ayares; Francisco Idalsoaga; Luis A Díaz; Jorge Arnold; Juan P Arab
Journal:  J Clin Exp Hepatol       Date:  2022-02-12

4.  Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice.

Authors:  Jason M Correnti; Egle Juskeviciute; Aditi Swarup; Jan B Hoek
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-17       Impact factor: 4.052

Review 5.  Treatment of Severe Alcoholic Hepatitis.

Authors:  Mark Thursz; Timothy R Morgan
Journal:  Gastroenterology       Date:  2016-03-04       Impact factor: 22.682

6.  Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis.

Authors:  Milan Sheth; Mark Riggs; Tushar Patel
Journal:  BMC Gastroenterol       Date:  2002-01-22       Impact factor: 3.067

7.  Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial.

Authors:  Ewan Forrest; Jane Mellor; Louise Stanton; Megan Bowers; Priscilla Ryder; Andrew Austin; Christopher Day; Dermot Gleeson; John O'Grady; Steven Masson; Anne McCune; David Patch; Paul Richardson; Paul Roderick; Stephen Ryder; Mark Wright; Mark Thursz
Journal:  Trials       Date:  2013-08-19       Impact factor: 2.279

8.  The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids.

Authors:  E H Forrest; A J Morris; S Stewart; M Phillips; Y H Oo; N C Fisher; G Haydon; J O'Grady; C P Day
Journal:  Gut       Date:  2007-07-12       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.